ES531911A0 - Procedimiento para la preparacion de nuevas 5-acil-2-(1h)-piridinonas. - Google Patents

Procedimiento para la preparacion de nuevas 5-acil-2-(1h)-piridinonas.

Info

Publication number
ES531911A0
ES531911A0 ES531911A ES531911A ES531911A0 ES 531911 A0 ES531911 A0 ES 531911A0 ES 531911 A ES531911 A ES 531911A ES 531911 A ES531911 A ES 531911A ES 531911 A0 ES531911 A0 ES 531911A0
Authority
ES
Spain
Prior art keywords
piridinonas
acil
procedure
preparation
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES531911A
Other languages
English (en)
Other versions
ES8505956A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of ES531911A0 publication Critical patent/ES531911A0/es
Publication of ES8505956A1 publication Critical patent/ES8505956A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES531911A 1983-04-29 1984-04-25 Procedimiento para la preparacion de nuevas 5-acil-2-(1h)-piridinonas. Expired ES8505956A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/490,081 US4568751A (en) 1983-04-29 1983-04-29 5-Acyl-2-(1H)-pyridinones

Publications (2)

Publication Number Publication Date
ES531911A0 true ES531911A0 (es) 1985-06-01
ES8505956A1 ES8505956A1 (es) 1985-06-01

Family

ID=23946554

Family Applications (2)

Application Number Title Priority Date Filing Date
ES531910A Expired ES8505955A1 (es) 1983-04-29 1984-04-25 Un procedimiento para preparar nuevas 5-acil-2-(1h)-piridinonas.
ES531911A Expired ES8505956A1 (es) 1983-04-29 1984-04-25 Procedimiento para la preparacion de nuevas 5-acil-2-(1h)-piridinonas.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES531910A Expired ES8505955A1 (es) 1983-04-29 1984-04-25 Un procedimiento para preparar nuevas 5-acil-2-(1h)-piridinonas.

Country Status (22)

Country Link
US (1) US4568751A (es)
EP (2) EP0124089B1 (es)
JP (2) JPS59206355A (es)
KR (2) KR900005010B1 (es)
AR (1) AR240313A1 (es)
AT (2) ATE26262T1 (es)
AU (2) AU557543B2 (es)
CA (2) CA1256880A (es)
DD (1) DD223444A5 (es)
DE (2) DE3462503D1 (es)
DK (2) DK159425C (es)
ES (2) ES8505955A1 (es)
GR (2) GR81990B (es)
HU (2) HU191928B (es)
IE (2) IE57273B1 (es)
IL (2) IL71648A (es)
NO (2) NO164415C (es)
NZ (2) NZ207961A (es)
PH (1) PH20256A (es)
PT (2) PT78491B (es)
SU (1) SU1299505A3 (es)
ZA (2) ZA843034B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4731371A (en) * 1984-03-29 1988-03-15 Merrell Dow Pharmaceuticals Inc. Certain 5-acyl-1,2-dihydro-2-oxo-3-pyridinecarbonitriles which are useful as cardiotonic agents
US5118696A (en) * 1983-04-29 1992-06-02 Merrell Dow Pharmaceuticals Inc. 5-Acyl-2-(1H)-pyridinones useful for treating cardiac failure
US4853395A (en) * 1983-04-29 1989-08-01 Merrell Dow Pharmaceuticals Inc. Certain 3-carboxylate or 3-carbamyl-5-acyl-2-(1H)-pyridinones having cardiotonic properties
US5428045A (en) * 1983-04-29 1995-06-27 Merrell Dow Pharmaceuticals Inc. 5-acyl-2-(1H)-pyridinoes
US4568751A (en) * 1983-04-29 1986-02-04 Merrell Dow Pharmaceuticals Inc. 5-Acyl-2-(1H)-pyridinones
US4992452A (en) * 1983-04-29 1991-02-12 Merrell Dow Pharmaceuticals Inc. Certain 5-acyl-2-(1H)-pyridinones useful in treating cardiac failure
US5212314A (en) * 1983-11-03 1993-05-18 Merrell Dow Pharmaceuticals Inc. Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
US4732982A (en) * 1983-11-03 1988-03-22 Merrell Dow Pharmaceuticals Inc. Novel alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
US4657919A (en) * 1984-08-03 1987-04-14 E. I. Du Pont De Nemours & Co. Pyridone esters as inotropic agents
US4650806A (en) * 1985-01-14 1987-03-17 Sterling Drug Inc. Cardiotonic 5-(heterylcarbonyl)-pyridones

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2531035A1 (de) * 1975-07-11 1977-01-27 Basf Ag Verfahren zur herstellung von 5-cyanpyridonen-(6)
US4072746A (en) * 1975-10-14 1978-02-07 Sterling Drug Inc. 3-Amino-5-(pyridinyl)-2(1H)-pyridinones
GB1596887A (en) * 1977-07-15 1981-09-03 Rohm & Haas 2-pyridone derivatives and their use as plant growth regulators
DE3005069A1 (de) * 1980-02-11 1981-08-20 Cassella Ag, 6000 Frankfurt Pyridonderivate, ihre herstellung und ihre verwendung
DE3106460A1 (de) * 1980-03-03 1982-01-28 Sandoz-Patent-GmbH, 7850 Lörrach 2(1h)-pyridinon-derivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen
US4412077A (en) * 1982-03-15 1983-10-25 Sterling Drug Inc. Process for preparing 5-(lower-alkanoyl)-6-(lower-alkyl)-2(1H)-pyridinone
US4524149A (en) * 1982-03-15 1985-06-18 Sterling Drug Inc. 5-Alkanoyl-6-alkyl-2(1H)-pyridinones, their preparation and their cardiotonic use
US4568751A (en) * 1983-04-29 1986-02-04 Merrell Dow Pharmaceuticals Inc. 5-Acyl-2-(1H)-pyridinones
DE3406329A1 (de) * 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt Pyridone

Also Published As

Publication number Publication date
ATE25678T1 (de) 1987-03-15
DK213584A (da) 1984-10-30
NO841690L (no) 1984-10-30
JPS59206355A (ja) 1984-11-22
IL71649A0 (en) 1984-07-31
HU191753B (en) 1987-04-28
ATE26262T1 (de) 1987-04-15
NO164415B (no) 1990-06-25
JPH0579668B2 (es) 1993-11-04
JPS59206356A (ja) 1984-11-22
PT78491A (en) 1984-05-01
AU2714184A (en) 1984-11-01
HUT34006A (en) 1985-01-28
PT78493B (en) 1986-05-20
AU2713184A (en) 1984-11-01
NO841691L (no) 1984-10-30
JPH058192B2 (es) 1993-02-01
PT78491B (en) 1986-05-22
IL71648A (en) 1987-11-30
DK159425B (da) 1990-10-15
IE841046L (en) 1984-10-29
DK159424C (da) 1991-03-18
CA1256880A (en) 1989-07-04
HU191928B (en) 1987-04-28
ZA843033B (en) 1984-11-28
CA1242443A (en) 1988-09-27
NZ207961A (en) 1986-09-10
NO164416C (no) 1990-10-03
NZ207960A (en) 1987-05-29
KR900005011B1 (ko) 1990-07-16
EP0124089B1 (en) 1987-03-04
EP0124090A1 (en) 1984-11-07
EP0124089A1 (en) 1984-11-07
DE3462889D1 (de) 1987-05-07
IL71649A (en) 1987-10-30
GR81990B (es) 1984-12-12
PH20256A (en) 1986-11-14
IE841047L (en) 1984-10-29
US4568751A (en) 1986-02-04
DE3462503D1 (en) 1987-04-09
HUT34007A (en) 1985-01-28
AU557543B2 (en) 1986-12-24
IE57285B1 (en) 1992-07-15
DK213584D0 (da) 1984-04-27
NO164416B (no) 1990-06-25
ES8505956A1 (es) 1985-06-01
ES531910A0 (es) 1985-06-01
KR840008323A (ko) 1984-12-14
DK213284D0 (da) 1984-04-27
IL71648A0 (en) 1984-07-31
KR840008322A (ko) 1984-12-14
DK213284A (da) 1984-10-30
KR900005010B1 (ko) 1990-07-16
PT78493A (en) 1984-05-01
ES8505955A1 (es) 1985-06-01
DK159424B (da) 1990-10-15
AU571219B2 (en) 1988-04-14
EP0124090B1 (en) 1987-04-01
SU1299505A3 (ru) 1987-03-23
DK159425C (da) 1991-03-18
IE57273B1 (en) 1992-07-01
NO164415C (no) 1990-10-03
AR240313A1 (es) 1990-03-30
ZA843034B (en) 1984-11-28
DD223444A5 (de) 1985-06-12
GR81967B (es) 1984-12-12

Similar Documents

Publication Publication Date Title
ES538231A0 (es) Procedimiento para la preparacion de derivado de esfingosina.
ES517167A0 (es) Procedimiento para la preparacion de nuevos bencimidazoles sustituidos.
ES533260A0 (es) Procedimiento para la preparacion de 13a-alquilgonanos
AR240449A1 (es) Procedimiento para la preparacion de polialquilenpoliaminas no ciclicas.
ES521870A0 (es) Procedimiento para la preparacion de nuevos benzo-heterociclos.
ES517988A0 (es) Procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil-bencimidazolonas sustituidas.
ES538621A0 (es) Procedimiento para la preparacion de fenolsulfonftaleinil-b-d-galactosidos
ES545151A0 (es) Procedimiento para la preparacion de n-piridilindoles
ES538464A0 (es) Procedimiento para la preparacion de derivados de acilamida.
ES532957A0 (es) Procedimiento para la preparacion de sulfonilureas substituidas
ES531911A0 (es) Procedimiento para la preparacion de nuevas 5-acil-2-(1h)-piridinonas.
ES546506A0 (es) Procedimiento para la preparacion de nuevos derivados de 3-fenil-4-cianopirrol.
ES520579A0 (es) Procedimiento para la preparacion de eteres oximicos.
AR240460A1 (es) Procedimeitno para la preparacion de derivados de antraciclina.
MX156242A (es) Procedimiento para la preparacion de eter-sulfonatos
ES519529A0 (es) Procedimiento para la preparacion de nuevas tienobenzodiazepinonas sustituidas.
ES535185A0 (es) Procedimiento para la preparacion de nuevas oxadiacinas
ES517153A0 (es) Procedimiento para la preparacion de nuevas acinorrifamicinas.
ES528114A0 (es) Procedimiento para la preparacion de hexanorbrassinolid-22-eteres
ES523990A0 (es) Procedimiento para la preparacion de furobenzoisoxazoles.
ES535373A0 (es) Procedimiento para la preparacion de nuevas pirazolil- e isoxazolilsulfonilureas
ES543366A0 (es) Procedimiento para la preparacion de derivados de feniletilamina.
ES539626A0 (es) Procedimiento para la preparacion de nuevas 3-alcoxi-2-(n-pirrolidino)-n-pirimidinil-o-n-pirazinil propilaminas.
MX159538A (es) Procedimiento para la preparacion de 3-acil-2-nitrometilen-tetrahidro-2h-1,3-tiazina
MX162546A (es) Procedimiento mejorado para la preparacion de 2-halogenoresorcinoles

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401